RECODE THERAPEUTICS, INC. of Menlo Park, CA, a company, filed a Form D amendment with the SEC on 2023-01-27. The offering totals $220.8M, of which $210.0M was reported sold. Industry: Biotechnology.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Shehnaaz S Suliman | Director | Menlo Park, CA |
| Shehnaaz S Suliman | Executive Officer | Menlo Park, CA |
| Peter A Thompson | Director | New York, NY |
| Rana S Al-Hallaq | Director | Menlo Park, CA |
| Patricia S Millican | Director | Menlo Park, CA |
| Shehnaaz Suliman | Director | Menlo Park, CA |
| Shehnaaz Suliman | Executive Officer | Menlo Park, CA |
| Shehnaaz Suliman | Promoter | Menlo Park, CA |
| Edward S Hurwitz | Director | Menlo Park, CA |
| Alan S Colowick | Director | Menlo Park, CA |
| David S Lockhart | Executive Officer | Menlo Park, CA |
| Dean S Mitchell | Director | Menlo Park, CA |
| Basheer S Zada | Director | Menlo Park, CA |
| Inai S Park | Director | Menlo Park, CA |
| Helen S Kim | Director | Menlo Park, CA |
| Rakhshita S Dhar | Director | Menlo Park, CA |
| Oleg S Nodelman | Director | Menlo Park, CA |
| Kouki S Harasaki | Director | Menlo Park, CA |
| Trisha S Millican | Director | Menlo Park, CA |
| Julia S Eastland | Executive Officer | Menlo Park, CA |
| RA S Session II | Director | Menlo Park, CA |
| David J Lockhart | Director | Menlo Park, CA |
| David J Lockhart | Executive Officer | Menlo Park, CA |
| Michael J Torres | Director | Menlo Park, CA |
| RA J Session II | Director | Menlo Park, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-10-23 | D | $29.4M | $29.4M |
| 2023-09-28 | D/A | $290.0M | $259.8M |
| 2022-07-06 | D/A | $200.0M | $160.0M |
| 2021-10-25 | D | $80.0M | $40.0M |
| 2020-03-20 | D | $80.0M | $27.5M |
| 2019-02-08 | D/A | $3.0M | $2.0M |
| 2017-03-02 | D/A | $3.0M | $1.0M |
| 2017-01-05 | D | $3.0M | $500K |